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More andmore cancer patients use complementary therapies. As themajority of patients do not disclose their use of complementary
therapies to their oncologists, they expose themselves to possible detrimental effects from the therapies due to drug interactions.
To meet the needs of patients and health care professionals on valid information on complementary therapies, the collaborative
research project “Competence Network Complementary Medicine in Oncology—KOKON”, an interdisciplinary network for
complementary medicine research in oncology, was established. Moreover, Integrative Oncology, a combination of conventional
and evidenced-based complementary therapies delivered using a comprehensive approach, is now increasingly used in the United
States and Europe. A variety of different Integrative Oncology models have been established worldwide including an expert-
based model at the Kliniken Essen-Mitte, Essen, Germany and a patient-centered, evidenced-based approach at The University
of Texas MD Anderson Cancer Center. Both models are briefly reviewed. More research is needed and Comparative Effectiveness
Research that places strong emphasis on the comparison of different treatment options in usual care settings by including more
heterogeneous patients, using less standardized treatment protocols, and measuring patient-centered outcomes would provide
useful information for decision-making. To improve the quality of care and research in Integrative Oncology, sustainable financial
models for Integrative Oncology and more funding for research are needed.
1. Integrative Oncology
With about 12.7 million new cases and 7.6 million deaths in
2008, cancer is the leading cause of death worldwide [1, 2].
While survival rates are increasing [3, 4], cancer diagnosis
and treatment are still often associated with physical and
psychosocial impairments.Whilemore than half of all cancer
patients report fatigue as a problem [5, 6], one out of three
cancer patients suffers from a mood disorder at some point
in their cancer care trajectory [7]. The most common com-
plaints in cancer patients concern pain, fatigue, depression,
and anxiety [5, 8].
Complementary and alternative medicine (CAM) is used
by about 40% of all cancer patients to manage symptoms
related to their disease, with varying estimates usually based
on the definition of CAM [9–12]. Patients normally do not
expect these approaches to cure their disease but mainly use
them to strengthen their immune system, relieve pain, or
manage treatment-related side effects [13]. As patient survival
rates are increasing, those needs of cancer survivors that go
beyond themere alleviation of symptoms are becomingmore
important for oncologists, psycho-oncologists, and other
oncology professionals. Many complementary therapies aim
to treat patients in a more comprehensive manner and
thus are also concerned with the patient’s psychological and
spiritual needs. Complementary oncological therapies are
classified by the Concerted Action for Complementary and
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AlternativeMedicine Assessment in the Cancer Field (CAM-
Cancer) as
(1) alternative medical systems (e.g., homeopathy, tradi-
tional Chinese medicine)
(2) biologically based practices (e.g., herbs, vitamins, and
food)
(3) energy medicine (e.g., reiki)
(4) manipulative and body-based practices (e.g., mas-
sage)
(5) mind-body medicine (e.g., meditation, yoga, and
progressive muscle relaxation) [14].
Complementary therapies are now even included worldwide
in the curricula of many medical schools [15, 16], including
such prestigious schools as Stanford University Medical
School, the Harvard Medical School, and the Charité Uni-
versity Medical Center in Berlin, Germany, to name a few. In
fact, the US-based Consortium of Academic Health Centers
for Integrative Medicine has over 50 academic centers as
part of their membership. In addition, integrative oncology
is now being implemented in various institutions such as the
Memorial Sloan-Kettering Cancer Center, The University of
Texas MD Anderson Cancer Center and other institutions in
the USA, Canada, and Europe [17, 18].
While alternative therapies are used instead of con-
ventional medicine, complementary therapies are used in
addition to conventional methods. Conventional clinicians
are more supportive of the use of complementary therapies
than alternative therapies as in the former the patients
are not foregoing treatments with known clinical benefit.
However, simultaneous administration of complementary
and conventional therapies always bears the risk that the
complementary treatment will interfere with the standard
treatment, for example, in the form of drug interactions,
partially with incalculable outcomes. Additionally, themajor-
ity of patients do not disclose their use of complementary
therapies to their health care team mainly due to lack of
inquiry; patient’s anticipation of the doctor’s disapproval,
disinterest, or inability to help; and patient’s perception that
disclosure of CAM use is irrelevant to their conventional
care [19].Thereby, they expose themselves to possible adverse
effects.These are especially due to the possible interactions of
complementary treatmentswith chemotherapy, radiotherapy,
endocrine treatment, or other targeted therapies. Integrative
oncology is a combination of conventional with complemen-
tary therapies that have been shown to be safe and effective
[20]. In contrast to alternative or complementary approaches,
Integrative oncology aims to combine the best practices of
conventional and complementary oncological therapy (the
“best of both worlds”). Thereby, conventional and com-
plementary therapies are united into one comprehensive,
patient-centered approach in order to maximize safety and
efficacy. As both treatment approaches are administered from
members of the same team, occasional interactions between
treatments can be recognized and the best possible outcomes
to meet patients’ needs can be ensured [21, 22].
2. The Relevance of Valid Patient Information
Themajority of cancer patients today want detailed informa-
tion about their cancer diagnosis, prognosis, and treatment
options [23], and information seeking has been demonstrated
to play a critical role in individuals’ efforts to cope with
the disease [23]. The benefits of information for cancer
patients include increased involvement in decision making
and greater satisfaction with treatment choices [24], reduc-
tions in psychological distress, and improved communica-
tion [25]. Patients most frequently seek treatment-related
information, such as treatment options and side effects
[26]. Cancer patients often expect important benefits from
complementary medicine. Irrespective of how well informed
patients are, a substantial percentage of patients still need
additional information, often about topics such as food, diet,
and complementary medicine treatment options; relatively
often, even patients already using complementary medicine
felt a need for additional information [27]. Likewise, they per-
ceived important unmet needs for readily accessible, credible,
relevant sources of complementary medicine information.
There is a strong need for more efficient, systematic, and
trustworthy information. Typically, patients have located
information under conditions of great stress and uncertainty
and would welcome improvements in that process [28].
To meet the needs of patients and health care profes-
sionals, the German Cancer Aid (Deutsche Krebshilfe) is
currently funding the collaborative research project “Com-
petence Network Complementary Medicine in Oncology-
KOKON”. KOKON is organized as a closely linked cluster of
seven work packages with the overall aim to develop, imple-
ment, and evaluate an interdisciplinary network for comple-
mentary medicine research in oncology. The work packages
and analyzes the needs for and offers information for cancer
patients and health care professionals around complementary
medicine and is working to develop a web-based information
platform. Furthermore, KOKON is engaged in the develop-
ment, implementation, and evaluation of a medical expert
consulting service for complementary medicine as well as
training programs for health care professionals and cancer
survivors. All methodological approaches are supported and
harmonized by a methodology center, in order to guarantee
high scientific quality. A coordination center ensures broad
cooperationwithin KOKON and amultidisciplinary board of
external experts assures supervision of the research project.
3. Clinical Models for Integrative Oncology
A substantial number of cancer patients use complementary
therapies to manage symptoms related to their disease or
conventional treatment [12]; the prevalence of complemen-
tary therapies use has almost doubled from the 1970s until
the 2000s [12]. The majority of patients use CAM methods
indiscriminately and without informing their oncologists
[11], exposing themselves to possible detrimental effects,
especially due to interactions with their conventional treat-
ments. Therefore, integrative oncology programs have been
established that can advise patients about both the benefits
and the possible negative effects of complementary therapy
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Table 1: Similarities and differences between the Integrative Oncology for Breast Cancer Program, Essen, Germany and the Integrative
Medicine Program, Houston, USA [29].
Integrative Oncology for Breast Cancer Program, Essen Integrative Medicine Program at MD Anderson CancerCenter, Houston
Center Breast cancer center offering conventional andintegrative medicine
Integrative medicine referral center open to all
conventional departments
Setting Inpatient and outpatient Inpatient and outpatient
Philosophy Holistic and patient-centered approach Holistic and patient-centered approach
Treatments
Mind-body medicine, acupuncture, massage therapy,
naturopathic treatments, nutrition, exercise,
phytotherapy
Mind-body medicine, acupuncture, massage therapy,
nutrition, exercise, music therapy, expressive arts,
support groups
Professional team Oncologists, physicians specialized in complementarymedicine, mind/body medicine instructors
Physicians specialized in both oncology and
complementary medicine, dieticians, meditation
instructors, chaplains, physical therapists,
acupuncturists, massage therapists, yoga instructors,
music therapists
Research Implementation of an evidence-based informationdatabase (“SenoExpert”)
Well-funded research program and cooperative projects
with other departments
treatments. A variety of different models are used worldwide
[18]; two such models are briefly introduced below. Simi-
larities and differences between the 2 models are shown in
Table 1. A more detailed comparison of the 2 models can be
found in [29].
3.1. Integrative Oncology for Breast Cancer Patients in Ger-
many: An Expert-Based Model. Since the beginning of 2010,
two departments of the Kliniken Essen-Mitte, academic
teaching hospital of the University of Duisburg-Essen, the
Department of Senology/Breast Center (medical director: PD
Dr. S. Kümmel), and the Department of Internal and Inte-
grative Medicine (Professor Dr. G. Dobos) have been coop-
erating in providing integrative oncology for breast cancer
patients.The treatment of each patient is organized according
to an individualized treatment plan based on the current
literature and treatment guidelines [30]. These treatment
plans are formulated based on detailed analyses of a patient’s
case and the results of their individual tumor conferences.
During this, the integrative oncology team, consisting of
physicians and complementary medicine therapists, reviews
current research literature and guidelines relevant to the
specific breast cancer patient. For this purpose, SenoExpert,
a special database for breast cancer patients, was developed
that is continually updated by scientists, physicians, and
therapists who regularly review the medical literature and
screen it for new guidelines. SenoExpert aims to make the
current guidelines and scientific evidence readily available
to physicians responsible for routine care. In addition,
experts discuss anonymized breast cancer cases at regular
intervals during online conferences. Besides conventional
oncological treatment every patient has the opportunity to
attend consultationswith complementary therapies physician
and mind-body medicine therapists, specially trained health
professionals with expertise in clinical psychology, nutrition,
exercise, and psycho-oncology. Treatment options include
acupuncture, phytotherapy, gua sha therapy, and cupping
massage while mind-bodymedical therapies include physical
Table 2: Number of selected complementary and alternative
medicine (CAM) treatments provided in the Integrative Oncology
for Breast Cancer Program, Essen, Germany in 2011 and 2012.
2011 2012
Body acupuncture 560 1043
Ear acupuncture 1587 1509
Mind-body medicine
(counseling, exercise, diet, relaxation, yoga, qigong) 548 1273
CAM treatments overall 4398 5838
exercise, yoga, mindfulness, training on coping strategies,
and nutrition in order to support patients in copingwith their
diseases and treatments [30]. SinceOctober 2010, the number
of CAM treatments provided is increasing each year (Table 2)
[30].
As the evidence base supports that mind-body medicine
is effective for improving health-related quality of life, psy-
chological, and physical health in cancer patients [31–33],
mind-body medicine is a crucial part of integrative oncol-
ogy at the Department of Complementary and Integrative
Medicine, Kliniken Essen-Mitte [30]. To deepen and consoli-
date the knowledge and skills acquired during their inpatient
stay, patients are offered participation in an 11-week mind-
body medicine day care clinic subsequent to their inpatient
stay [34].This program is open for but not limited to patients
who underwent inpatient treatment at the Kliniken Essen-
Mitte. So far, about 1500 cancer patients have participated in
this program [34]. Based on the Mindfulness-Based Stress
Reduction (MBSR) Program developed by Kabat-Zinn at
the University of Massachusetts [35, 36] and the mind-body
medicine cancer program of the Benson-Henry Mind/Body
Medical Institute atHarvardMedical School [37], the day care
program integrates cognitive therapy, meditation, yoga, exer-
cise training, nutritional lectures in a teaching kitchen, and
self-care strategies (e.g., cupping massage [38], hydrother-
apy). In addition, during weekly group medical rounds,
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patients can discuss their current medical status and their
progress over the course of the program with an integrative
oncologist. The effectiveness of the day care program has
already been investigated in a number of clinical trials [39–
41].
Beyond inpatient and outpatient care, the Breast Center
and the Department of Internal and Integrative Medicine,
Kliniken Essen-Mitte, work closely together to improve the
quality of integrative oncology training: a curriculum for
advanced training of physicians has been developed and
an official qualification in integrative oncology is currently
being accredited. Moreover, in order to improve the evidence
base for including complementary therapies in treatment
plans for cancer patients, both departments are involved in
the development of medical guidelines in 2011 and 2013, in
cooperation with the study group for gynecologic oncology
(AGO).
3.2.The IntegrativeMedicine ProgramatMDAndersonCancer
Center. The Integrative Medicine Program at MD Anderson
focuses on creating a comprehensive and integrative care plan
that addresses the whole person with a cancer diagnosis. The
Program’s mission focuses on three areas: clinical delivery,
education, and research. The main objectives of these areas
are as follows: (1) Clinical: to provide the highest quality
integrative medicine therapies to patients and their families
using a patient-centered approach.The therapies are provided
in concert with mainstream care to manage symptoms,
relieve stress, and enhance quality of life; (2) Education: offer
reliable information on integrative medicine interventions
to patients, families, and medical staff of MD Anderson;
and (3) Research: advance knowledge on the outcome and
effectiveness of integrative therapies through peer-reviewed,
mixed-methodology research.
The Integrative Medicine Program at MD Anderson is
an important component of the mission to treat the whole
person—from prevention and treatment through survivor-
ship. Ongoing research is examining intervention programs
and treatments that can improve quality of life and clinical
outcomes. Educational programs provide information to
our faculty, staff, students, trainees, and the public about
complementary and integrative medicine (CIM) approaches.
The Integrative Medicine Center, the clinical delivery
component of the program, offers integrative oncology
consultation with an oncologist with CIM training and
focuses on the use of CIM throughout the cancer care
continuum. These consultations are initiated by the primary
oncologist similar to a referral to another specialty. During
this consultation, the integrative oncologist reviews details
regarding the cancer history and treatment plan, gaining an
understanding of each patient’s needs and reasons for CIM
interest. This discussion ranges from providing expertise in
natural products, including nutritional supplements, vita-
mins and herbs, to incorporatingmind-body techniques such
as music therapy and meditation. Other topics may focus
on managing pain, stress and anxiety, and other symptoms
resulting from illness and/or treatment side effects. The
goals are to help the patient obtain optimal health and
healing through a treatment plan that is comprehensive,
integrative, personalized, evidence-based, and safe. Close
collaborationwith the primary oncology team is essential and
treatment plans are placed within the context of the patient’s
goals of care. Challenging cases are discussed at a weekly
multidisciplinary team meeting to develop individualized
treatment plans. The treatment plans commonly involve
multiple health practitioners including dieticians, medita-
tion instructors, chaplains, physical/occupational therapists,
acupuncturists, massage therapists, yoga instructors, music
therapists, and others. Both individual and group programs
are provided to patients and caregivers. Individual services
include consultation with an integrative oncologist, dietary
and exercise consultations,meditation/psychological consult,
acupuncture, massage, and music therapy. Group programs
include a number of different mind-body and movement-
based practices (e.g., meditation, yoga, tai chi, qigong, and
Pilates), nutrition classes, music therapy, expressive arts,
support groups, and more. An inpatient consult services is
also available.
4. The Challenges and the Future of
Clinical Research
Integration should be based on evidence and the gap between
the usage in cancer patients and the available clinical evidence
is still large. Furthermore, there is an ongoing discussion
in the field of medicine about which type of evidence
might be the most suitable. Despite the decades of effort to
provide solid evidence of the efficacy and effectiveness of
interventions, results have yielded relatively little evidence to
support health care decisions. For stakeholders (e.g., patients,
payers, clinicians, and policy makers), the available evidence
on specific treatment effects often fails to provide clarity
for decision makers when they are confronted by choices
between and among a variety of options for a heterogeneous
patient population.The rigor in randomized studies, wherein
patients with comedication and comorbidities are often
excluded and treatments are highly standardized, has largely
provided results that are poorly generalizable.
Comparative effectiveness research (CER) is a more
recent development in clinical research that places strong
emphasis on the comparison of different treatment options
in usual care settings by including more heterogeneous
patients, using less standardized treatment protocols, and
measuring patient-centered outcomes [42]. The Institute of
Medicine in the US identified cancer as one priority for CER
[43] and a strategic framework for how to perform CER
in the field of oncology was developed by the Center for
Medical Technology Policy [44]. In general, a broad spectrum
of methods—from registries to randomized trials—can be
applied to CER.The strategic framework for CER in the field
of complementary and integrative medicine concluded that
CER should be prioritized and CER study designs should
focus on effectiveness rather than on efficacy [45]. “Efficacy”
refers to “the extent to which a specific intervention is
beneficial under ideal conditions,” whereas “effectiveness”
is a measure of the extent to which an intervention, when
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deployed in the field in routine circumstances, does what it
is intended to do for a specific population [46].
Integrative oncology is a field particularly well suited
for CER, because it often deals with the use of both
conventional and complementary treatments and points to
patient populations that usually have comorbidities and use
a broader range of medications. By fostering study designs
that emphasize broader inclusion criteria,morewide-ranging
outcomes (including quantitative and qualitative outcomes),
subgroup analyses, stakeholder input, usual care settings,
and flexible treatment protocols, CER has the potential to
yield important evidence for decision makers in the field of
integrative oncology.
5. Conclusions
Complementary therapies are increasingly requested by can-
cer patients and integrative oncology programs are estab-
lished worldwide to serve their needs. In order to improve
the quality of care for cancer patients, more clinical research
is needed to investigate effective and safe combinations of
conventional and complementary treatments. In particular,
more funding for research that is relevant for clinical decision
making is urgently needed. Also, in order to establish clinical
guidelines, a systematic review of the current literature is
necessary. To improve the knowledge of clinicians work-
ing in integrative oncology, the development of curricula
for integrative oncology summarizing the evidence-based
procedures that are safe and effective is urgently needed.
To facilitate the extensive worldwide implementation of
integrative oncology, sustainable financial models for clinical
care are needed.
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